News & Media

UCLH
Ridge involved in innovative Proton Beam Therapy Centre
17.4.2015

Health secretary Jeremy Hunt has unveiled plans for a new Proton Beam Therapy (PBT) Centre at University College London Hospitals NHS Foundation Trust (UCLH). The new centre will offer highly specialist treatment that has not been available in the UK before. The Ridge team in London is proud to be heavily involved in this innovative project, providing Cost Management, Contract Administrative and Project Management services through a number of the project phases.

Ridge has a strong relationship with UCLH having successfully worked with the client on various projects since 2009. Ridge was initially appointed to assist in the development of business cases for PBT centres at both UCLH and The Christie NHS Foundation Trust in Manchester for the Department of Health. The two projects, which are scheduled to be completed from 2018, aim to build world-leading PBT capacity for treating cancer patients at both UCLH and the Christie Trust hospitals.

Following our early involvement, Ridge was appointed Quantity Surveyor on the UCLH scheme, helping guide UCLH through a complex tendering procedure with both the main contractors and a leading edge PBT equipment supply contractor. Ridge was then later appointed as Project Manager up until the enabling works commenced. Our Project Management role has since been extended to include the enabling works contract. Ridge will continue to provide Cost Management services throughout the project, working closely with UCLH on this innovative hospital.

This complex and specialist building includes four below ground basement levels, which will house a PBT unit and a surgery centre with eight operating theatres. Above, the building will provide Europe’s largest haematological inpatient medical facility and a short stay surgical unit.

Proton Beam Therapy is a form of radiotherapy that uses a beam of high–energy particles to destroy cancer cells more precisely. This increases success rates and reduces side-effects, such as deafness, loss of IQ and secondary cancers.

Ridge is delighted to be involved in such pioneering project, and is looking forward to continually working with UCLH to help improve future healthcare.


Leave a Reply